Purdue takes over production of TB drug

December 11, 2007
Eli Lilly and Co. has completed shifting exclusive production of a tuberculosis antibiotic to Purdue Research Foundation.

The foundation's Chao Center for Industrial Pharmacy & Contract Manufacturing will manufacture and distribute the drug, called Seromycin. Lilly sold the rights for an undisclosed price and donated the manufacturing equipment.

Approximately 10,000 Americans are thought to have a form of the disease that is resistant to other antibiotics.
Source: XMLFULL/XMLFull8667.xml

Recent Articles by IBJ Staff

Comments powered by Disqus